膜突蛋白抗体与血管内皮损伤相关疾病的初步研究The preliminary study of clinical relevance of anti-moesin antibody in patients with endothelial injury
毛华,杨晓武,杜峰,胥勇,朱晋坤,文美,刘廷筑
摘要(Abstract):
目的探讨膜突蛋白(moesin)及moesin抗体与血管内皮损伤相关疾病的临床相关性。方法利用纯化的重组moesin作为抗原建立间接ELISA,在实验中测定抗原最佳包被浓度、抗体最佳稀释浓度及酶标二抗最佳稀释倍数等。采用酶联免疫吸附法检测120例血管内皮损伤相关疾病[急性冠脉综合征(ACS)20例、原发性高血压30例、颈动脉硬化20例、糖尿病20例及高脂血症30例]患者及健康对照组120例健康体检者血清中抗moesin抗体。结果抗moesin抗体在120例血管内皮损伤相关疾病的阳性检出率较高,达25%~70%,显著高于正常对照组的5%(χ2=55.679,P<0.01);其中ACS组阳性检出率最高达70%,明显高于其他疾病组(χ2=11.774,P<0.05),其他各亚型疾病组之间差异无统计学意义(χ2=1.731,P>0.05)。结论抗moesin抗体在血管内皮损伤相关疾病的患者中有较高的检出率,虽然在伴有单一的导致血管内皮损伤危险因素的高血压、高血脂、糖尿病的患者中抗moesin抗体阳性检出率稍低,但在这些危险因素的协同作用下引起的ACS患者中抗moesin抗体阳性检出率较高。提示抗moesin抗体对于诊断血管内皮损伤,作为一个全新的诊断线索有一定的临床价值。
关键词(KeyWords): 连接蛋白类;抗体;内皮,血管;创伤和损伤
基金项目(Foundation):
作者(Author): 毛华,杨晓武,杜峰,胥勇,朱晋坤,文美,刘廷筑
参考文献(References):
- [1]Koss M,Pfeiffer GR2nd,Wang Y,et al.Ezrin/radixin/moesin proteins are phosphorylated by TNF-a and modulate permeability increases in human pulmonary microvascular endothelial cells.J Immunol,2006,176:1218-1227.
- [2]Pradeep CR,Sunila ES,Kuttan G,et al.Expression of vascular endothelial growth factor(VEGF)and VEGF receptors in tumor angiogenesis and malignancies.Integr Cancer Ther,2005,4:315-321.
- [3]Tsukita S,Yonemura S.ERM(ezrin/radixin/moesin)family:from cytoskeleton to signal transduction.Curr Opin Cell Biol,1997,9:70.
- [4]Polesello C,Payre F.Small is beautiful:what flies tell US aboutERM protein function in development.Trends Cell Biol,2004,14:294-302.
- [5]Takamatsu H,Feng X,Chuhjo T,et al.Specific antibodies to moesin,a membrane-cytoskeleton linker protein,are frequently detected in patients with acquired aplastic anemia.Blood,2007,109:2514-20.
- [6]赵久良,李梦涛,王迁田,等.特异性抗膜突蛋白抗体在结缔组织病肺部受累早期诊断中的意义.中华风湿病学杂志,2010,14:88-90.
- [7]Wolfort RM,Stokes KY,Granger DN,et al.CD4T lymphocytcs mediate hypercholesterolemia.induced endothelial dysfunction via a NAD(P)H oxidase-dependent mechanism.Am J Physiol Heart Circ Physiol,2008,294:H2619-H2626.
- [8]Mattia DG,Bravi MC,Laurenti O,et al.Endothelial dysfunction and oxidative stress in type1and type2diabetic patients without clinicat macrovascular complications.Diaetes Res Clin Pract,2008,79:337.